Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Advances in Therapy（2021）
关键词
Anti-JCV antibody negative,Magnetic resonance imaging,Natalizumab,No evidence of disease activity,Relapsing-remitting multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要